Home > Drug Search >
  • company_query: Bionor Immuno
  •   > 
Drug Filter
Category:
chemistry (10) biology (35)
Status:
Approved (10) NDA Filing (1) BLA Filing (2) Phase Ⅲ (9) Phase Ⅱ (8) Phase Ⅰ (15)
Clinical Stage:
Pending (2) Active (27) Discontinued (6)
Bio-Type:
Cell therapy (2) Vaccine (20) Animal extract (1) Recombinant enzyme (1) Recombinant cytokines (7) Whole antibody (4)
Indication:
Alzheimer's disease (AD) (1) Amyotrophic lateral sclerosis (ALS) (1) Atherosclerosis (3) Candidiasis (1) Crohn's disease (1) Deep vein thrombosis (DVT) (1) HBV infection (2) HCV infection (2) HIV infection (2) Hyperlipidemia (1) Hyperuricemia (1) Influenza virus infection (1) Rabies (1) Major depressive disorder (MDD) (1) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (2) Myocardial infarction (MI) (1) Ovarian cancer (1) Parkinson's disease (PD) (1) Pneumonia (1) Postmenopausal osteoporosis (1) HEV infection (1) Diphtheria (1) Pertussis (2) Prostate cancer (1) Poliomyelitis (1) Tetanus (1) Psoriatic arthritis (1) Rheumatoid arthritis (RA) (1) Lactose intolerance (1) Rotavirus infection (1) Ulcerative colitis (1) Venous thromboembolism (VTE) (1) Cervical intraepithelial neoplasia (1) Dysentery (1) Ankylosing Spondylitis (AS) (1) Vaginal candidiasis (1) Muscle hypertonia (1) Diabetic foot ulcers (1) Tinea versicolor (1) Unstable angina (1) Cervical carcinoma (1) Malaria (3) Neutropenia (2) Multiple system atrophy (1) Plaque psoriasis (1) High-grade cervical intraepithelial neoplasia (1) Ebola virus disease (EVD) (2) Seborrhoeic dermatitis (1) Skin disorders (2) Human papillomavirus infections (HPV) (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top